MAVERICK CAPITAL LTD
Institutional investor · Portfolio as of Q2 2020
Top Holdings563 positions
Stock | Shares | Value | Weight | Avg Buy | Est. P&L | Held | Conviction |
|---|---|---|---|---|---|---|---|
META PLATFORMS INC-CLASS A | 1.7M | $385.3M | 8.1% | $199.54 | +9.81% | 6 qtrssince 2019-Q1 | Increased 98 |
HUMANA INC | 776,182 | $301M | 6.3% | $273.58 | +32.04% | 6 qtrssince 2019-Q1 | Decreased 0 |
MICROSOFT CORP | 1.5M | $295.6M | 6.2% | $140.15 | +35.18% | 6 qtrssince 2019-Q1 | Increased 70 |
DUPONT DE NEMOURS INC | 5.3M | $279.2M | 5.9% | $67.09 | -11.31% | 5 qtrssince 2019-Q2 | Decreased 0 |
ALPHABET INC-CL C | 186,972 | $264.3M | 5.6% | $58.04 | +19.28% | 6 qtrssince 2019-Q1 | Decreased 0 |
AMAZON.COM INC | 92,897 | $256.3M | 5.4% | $120.02 | +11.66% | 2 qtrssince 2020-Q1 | Increased 96 |
NETFLIX INC | 469,443 | $213.6M | 4.5% | $29.80 | +50.05% | 5 qtrssince 2019-Q2 | Increased 58 |
ALIBABA GROUP HOLDING-SP ADR | 847,477 | $182.8M | 3.8% | $167.37 | +22.01% | 6 qtrssince 2019-Q1 | Decreased 0 |
DOLLAR TREE INC | 1.9M | $178.6M | 3.8% | $93.67 | 0.00% | 3 qtrssince 2019-Q4 | Increased 90 |
ALNYLAM PHARMACEUTICALS INC | 1.1M | $164.9M | 3.5% | $88.39 | +67.33% | 6 qtrssince 2019-Q1 | Decreased 0 |
CROWN HOLDINGS INC | 2.3M | $148.7M | 3.1% | $65.70 | -6.71% | 3 qtrssince 2019-Q4 | Decreased 0 |
1LIFE HEALTHCARE INC COM | 3.5M | $121M | 2.5% | — | — | 2 qtrssince 2020-Q1 | Decreased 0 |
NEKTAR THERAPEUTICS | 5.2M | $120.1M | 2.5% | — | — | — | — |
Atara Biotherapeutics, Inc. | 6.8M | $98.4M | 2.1% | — | — | — | — |
KKR & CO INC | 2.8M | $86.4M | 1.8% | — | — | — | — |
AVANTOR INC | 5M | $85.7M | 1.8% | $15.88 | +3.88% | 3 qtrssince 2019-Q4 | Decreased 0 |
MOMENTA PHARMACEUTICALS INC | 2.3M | $77M | 1.6% | — | — | 2 qtrssince 2020-Q1 | Increased 50 |
LAM RESEARCH CORP | 231,888 | $75M | 1.6% | — | — | — | — |
BRITISH AMERICAN TOB-SP ADR | 1.7M | $66M | 1.4% | $24.53 | +2.34% | 6 qtrssince 2019-Q1 | Decreased 0 |
AIR PRODUCTS & CHEMICALS INC | 266,056 | $64.2M | 1.4% | $206.22 | +0.68% | 2 qtrssince 2020-Q1 | Increased 75 |
MAVERICK CAPITAL LTD manages $4.8B across 563 positions as of Q2 2020. Top holdings: META (8.1%), HUM (6.3%), MSFT (6.2%). Fund DNA: Momentum Trader. HoldingsIntel Rating: 1/5.0.
Active quarter - 265 new positions, 168 exits, 108 increased. Top move: META (INCREASED, conviction 98). Portfolio: $4.8B across 563 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Winners
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer